Thursday, July 23, 2020

Cipla Set To Launch Favipiravir Drug For Treatment Of COVID Patients

Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients,...

from NDTV News - Latest https://ift.tt/2ORjxma
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US-Bound F-35 Parts End Up In China, Probe Launched: Report

The shipment included an F-35 canopy, a key component of the aircraft's stealth system. The equipment was being moved by a broker, but i...